Table 2.
Study | LNR | NPN | TNE |
---|---|---|---|
Pawlik et al.24 | Yes | – | No |
House et al.16 | Yes | Yes | No |
Riediger et al.25 | Yes | Yes | No |
Massucco et al.22 | Yes | Yes | No |
Showalter et al.28 | Yes | Yes | Yes |
Bhatti et al.14 | Yes | – | No |
Murakami et al.23 | No | Yes | No |
La Torre et al.18 | Yes | – | No |
Sanjay et al.27 | Yes | – | – |
Robinson et al.26 | Yes | – | – |
Ausborn et al.13 | Yes | – | – |
John et al.17 | Yes | Yes | No |
Yamamoto et al.30 | Yes | Yes | No |
Strobel et al.29 | No | Yes | Yes |
La Torre et al.19 | Yes | No | Yes |
Liu et al.20 | Yes | Yes | No |
Malleo et al.21 | Yes | Yes | No |
Zhan et al.31 | Yes | – | No |
Fischer et al.15 | Yes | Yes | – |
LNR, lymph node ratio; NPN, number of positive nodes; TNE, total nodes examined; Yes = associated with overall survival; No = not associated with overall survival